Qiagen Expands NGS Portfolio with Oncology and Immunooncology Panels
The research panels can be performed using Qiagen’s GeneReader NGS system and other platforms, providing deep analysis of disease-related genomic mutations.
Read More
Search Results for: lung cancer
Test Predicts Primary Resistance to Anti-PD-1 Immunotherapy against Non-Small Cell Lung Cancer
The serum proteomic test could optimize treatment by identifying patients unlikely to benefit from immunotherapy.
Read More
Natera and Neon Therapeutics Collaborate to Assess Treatment Response to Personal Cancer Vaccine
The partners’ study combines Neon’s personal neoantigen vaccine and Signatera’s circulating tumor DNA assay in a trial for metastatic non-small cell lung cancer.
Read More
Protagen and German National Center for Tumor Diseases, Heidelberg, to Investigate Immunocompetence of Cancer Patients
Protagen has extended its collaboration with the National Center for Tumor Diseases, Heidelberg, to investigate the immunocompetence of urothelial cancer patients receiving immunotherapy.
Read MoreCreating More Accurate Measurements of NSCLC Treatment Response
Droplet digital PCR is rapidly becoming an invaluable tool in cancer treatment research.
Read More